Julie Methot
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Causality assessment of adverse events by healthcare professionals in an academic hospital setting: a descriptive retrospective study.
Journal: Canadian journal of physiology and pharmacology
Published: February 21, 2025
Serious Adverse Events: A Replicability and Validation Study of Naranjo Causality Assessment Tool in a Canadian Clinical Setting.
Journal: Journal of evaluation in clinical practice
Published: August 15, 2024
Underreporting of adverse events to health authorities by healthcare professionals: a red flag-raising descriptive study.
Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care
Published: July 24, 2024
Description of Pharmacist Interventions Based on Pharmaceutical Care and a Vulnerability Scoring Tool in a Tertiary Care Centre.
Journal: The Canadian journal of hospital pharmacy
Published: July 18, 2024
Impact of Vanessa's Law on the Reporting of Serious Adverse Events: A Retrospective Study Among Antiplatelet Users in a Tertiary-Care Cardiology Centre.
Journal: CJC open
Published: July 11, 2024
Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.
Journal: Journal of applied biomedicine
Published: December 14, 2022
Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: October 03, 2022
Reporting Rates of Opioid-Related Adverse Events Since 1965 in Canada: A Descriptive Retrospective Study.
Journal: Drugs - real world outcomes
Published: August 09, 2021
Title Not Found
Journal: Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec
Published: September 12, 2018
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Journal: Human gene therapy
Published: July 15, 2016
Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.
Journal: Human gene therapy
Published: December 05, 2013
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Journal: Gene therapy
Published: June 22, 2012
Last Updated: 09/26/2026